Xian Chen

Title: Innovations by Inventor Xian Chen

Introduction

Xian Chen is a notable inventor based in North Chelmsford, MA, with a significant contribution to the field of allergenic proteins and peptides. He holds a total of seven patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Among his latest patents, Xian Chen has developed innovative solutions related to allergenic proteins and peptides derived from Japanese cedar pollen. His invention provides nucleic acid sequences coding for major pollen allergens such as Cry j I, Cry j II, Jun s I, and Jun v I. These innovations are crucial for diagnosing, treating, and preventing Japanese cedar pollinosis. Additionally, he has created isolated peptides of Cry j I and Cry j II, which include T cell epitopes that enhance therapeutic properties while minimizing side effects. Another significant patent focuses on T cell epitopes of major allergens from house dust mites, offering methods for treatment and diagnosis of sensitivity to these allergens.

Career Highlights

Xian Chen has worked with prominent companies in the pharmaceutical industry, including Immunologic Pharmaceutical Corporation and Merck Patent GmbH. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Xian Chen has collaborated with notable professionals in his field, including Richard D. Garman and Mei-chang Kuo. These collaborations have likely enriched his research and development efforts.

Conclusion

Xian Chen's contributions to the field of allergenic proteins and peptides demonstrate his commitment to improving healthcare through innovation. His patents reflect a deep understanding of the complexities of allergens and their impact on human health.